189 related articles for article (PubMed ID: 23599070)
1. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
[TBL] [Abstract][Full Text] [Related]
3. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer--does tumor volume correlate with central necrosis and tumor pathology?
Tsou YA; Hua JH; Lin MH; Tsai MH
ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):206-12. PubMed ID: 16508339
[TBL] [Abstract][Full Text] [Related]
5. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience.
Preuss SF; Dinh V; Klussmann JP; Semrau R; Mueller RP; Guntinas-Lichius O
Oral Oncol; 2007 Apr; 43(4):402-7. PubMed ID: 17071133
[TBL] [Abstract][Full Text] [Related]
6. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
7. Comorbid predictors of poor response to chemoradiotherapy for laryngeal squamous cell carcinoma.
Hu M; Ampil F; Clark C; Sonavane K; Caldito G; Nathan CA
Laryngoscope; 2012 Mar; 122(3):565-71. PubMed ID: 22252981
[TBL] [Abstract][Full Text] [Related]
8. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
9. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment.
Denittis AS; Machtay M; Rosenthal DI; Sanfilippo NJ; Lee JH; Goldfeder S; Chalian AA; Weinstein GS; Weber RS
Am J Otolaryngol; 2001; 22(5):329-35. PubMed ID: 11562884
[TBL] [Abstract][Full Text] [Related]
10. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.
Lee WM; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Ryu SY
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):219-23. PubMed ID: 22326616
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal carcinoma in young adults: an alarming national trend.
Gayar OH; Ruterbusch JJ; Elshaikh M; Cote M; Ghanem T; Hall F; Siddiqui F
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):594-601. PubMed ID: 24452304
[TBL] [Abstract][Full Text] [Related]
15. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
16. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
Lacy PD; Spitznagel EL; Piccirillo JF
Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
[TBL] [Abstract][Full Text] [Related]
17. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal.
Mullen JT; Rodriguez-Bigas MA; Chang GJ; Barcenas CH; Crane CH; Skibber JM; Feig BW
Ann Surg Oncol; 2007 Feb; 14(2):478-83. PubMed ID: 17103253
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of presentation-to-diagnosis interval in patients with oropharyngeal carcinoma.
Ho T; Zahurak M; Koch WM
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):45-51. PubMed ID: 14732767
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
